Literature DB >> 9113267

Co-metabolism of ethanol, ethanol-derived acetaldehyde, and 4-hydroxynonenal in isolated rat hepatocytes.

D P Hartley1, D R Petersen.   

Abstract

Our laboratory has previously reported on the ability of 4-hydroxynonenal (4-HNE), a primary product of lipid peroxidation, to inhibit acetaldehyde metabolism in isolated mouse liver mitochondria. The purpose of the present study is to determine whether the co-metabolism of ethanol and 4-HNE compromises the elimination of either substrate in isolated rat hepatocytes. Hepatocytes were isolated and incubated with ethanol and 4-HNE. Ethanol elimination and acetaldehyde accumulation were monitored by gas chromatography, whereas 4-HNE elimination and metabolite accumulation were measured by UV detection and reversed-phase HPLC at 202 nm. In the absence of 4-HNE, hepatocytes metabolized ethanol at an initial rate of 9.4 nmol/min/million cells. Ethanol elimination was moderately inhibited by the presence of 4-HNE. Accumulation of ethanol-derived acetaldehyde was not apparent in incubations with only ethanol. In contrast, in incubations containing both substrates, ethanol-derived acetaldehyde accumulation exceeded that observed in hepatocytes exposed only to ethanol and was proportional to the 4-HNE concentration in the incubations. In all instances, the rate of 4-HNE elimination was not compromised by the presence of ethanol. Accordingly, ethanol metabolism did not alter the oxidative or conjugative metabolism of 4-HNE. However, the reductive metabolism of 4-HNE was affected by the presence of ethanol, wherein accumulation of 1,4-dihydroxy-2-nonene increased > 2-fold of that observed in incubations with only 4-HNE. To determine further if 4-HNE and ethanol are metabolized through the same metabolic pathways, cells were preincubated with either 4-methylpyrazole or cyanamide to inhibit alcohol dehydrogenase (E.C. 1.1.1.1.) and aldehyde dehydrogenase (E.C. 1.2.1.2.), respectively. Expectantly, 4-methylpyrazole blocked the formation of 1,4-dihydroxy-2-nonene, but had no effect on the rate of 4-HNE elimination. In contrast, cyanamide substantially inhibited the formation of 4-hydroxy-2-nonenoic acid, decreased the rate of 1,4-dihydroxy-2-nonene formation, but did not decrease the elimination rate of 4-HNE. Overall, these results support our previous observation that 4-HNE inhibits acetaldehyde metabolism and establish that ethanol and 4-HNE are metabolized through the same alcohol dehydrogenase- and aldehyde dehydrogenase-mediated pathways. These data continue to suggest that, as a consequence of enhanced lipid peroxidation resulting from chronic ethanol consumption, increased 4-HNE levels could compromise cellular elimination of ethanol-derived acetaldehyde and thus function in the potentiation of alcoholic liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113267

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  9 in total

1.  Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibition by 4-hydroxynonenal leads to increased Akt activation in hepatocytes.

Authors:  Colin T Shearn; Rebecca L Smathers; Benjamin J Stewart; Kristofer S Fritz; James J Galligan; Numsen Hail; Dennis R Petersen
Journal:  Mol Pharmacol       Date:  2011-03-17       Impact factor: 4.436

2.  Sequence tagging reveals unexpected modifications in toxicoproteomics.

Authors:  Surendra Dasari; Matthew C Chambers; Simona G Codreanu; Daniel C Liebler; Ben C Collins; Stephen R Pennington; William M Gallagher; David L Tabb
Journal:  Chem Res Toxicol       Date:  2011-01-07       Impact factor: 3.739

3.  Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal.

Authors:  Brante P Sampey; Benjamin J Stewart; Dennis R Petersen
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

4.  Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.

Authors:  Milton Hamblin; David B Friedman; Salisha Hill; Richard M Caprioli; Holly M Smith; Michael F Hill
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

5.  Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver.

Authors:  Rebecca L Smathers; James J Galligan; Colin T Shearn; Kristofer S Fritz; Kelly Mercer; Martin Ronis; David J Orlicky; Nicholas O Davidson; Dennis R Petersen
Journal:  J Lipid Res       Date:  2013-01-28       Impact factor: 5.922

6.  Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis.

Authors:  C T Shearn; R L Smathers; D S Backos; P Reigan; D J Orlicky; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2013-07-17       Impact factor: 7.376

7.  Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury.

Authors:  Evan P Gallagher; Christiaan M Huisden; James L Gardner
Journal:  Toxicol In Vitro       Date:  2007-04-27       Impact factor: 3.500

8.  Oxidative Stress and the ER Stress Response in a Murine Model for Early-Stage Alcoholic Liver Disease.

Authors:  James J Galligan; Rebecca L Smathers; Colin T Shearn; Kristofer S Fritz; Donald S Backos; Hua Jiang; Christopher C Franklin; David J Orlicky; Kenneth N Maclean; Dennis R Petersen
Journal:  J Toxicol       Date:  2012-07-05

Review 9.  Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury.

Authors:  Wiramon Rungratanawanich; Ying Qu; Xin Wang; Musthafa Mohamed Essa; Byoung-Joon Song
Journal:  Exp Mol Med       Date:  2021-02-10       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.